Skip to content
healthcare.dev

Cefepime

NDC 67184-1002, CEFEPIME HYDROCHLORIDE, injection, powder, for solution, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-1002
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203704
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-1002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEFEPIME HYDROCHLORIDE500 mg/1

Pharmacologic classes

Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]

Package NDCNDC-11Package
67184-1002-16718410020110 VIAL in 1 CARTON (67184-1002-1) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80b4c811-4a71-47fb-8565-85ce9d0f782c

Use it

Look up 67184-1002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-1002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-1002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.